Concepedia
Publication | Open Access
Acalabrutinib in relapsed or refractory mantle cell lymphoma (ACE-LY-004): a single-arm, multicentre, phase 2 trial
428
Citations
18
References
2017
Year
Lymphoid NeoplasiaOncologyPathologyPhase 2Medicine
Page 1